Can ursodeoxycholic acid capsules lower gamma-glutamyl transferase?
Sep 29, 2024
Source: Cainiu Health
Dr. Yang Ziqi
Introduction
When using ursodeoxycholic acid capsules, patients should follow their doctor's instructions, take the medication on time and in the prescribed dosage, and pay attention to observing the drug's efficacy and any adverse reactions. During treatment, patients should maintain healthy lifestyle habits, avoid consuming high-fat foods and alcohol, undergo regular check-ups, and monitor changes in liver function parameters. The underlying cause of any elevation should be analyzed accordingly.
In general, whether ursodeoxycholic acid capsules can reduce gamma-glutamyl transferase (GGT) levels depends on the underlying cause of the elevation. If elevated GGT is due to liver disease, ursodeoxycholic acid capsules may help lower its levels. However, if the elevation is caused by kidney disease, these capsules have only limited anti-inflammatory effects and are not effective in reducing GGT levels. If any discomfort occurs, prompt medical consultation is recommended. The detailed analysis is as follows:
When the liver is damaged or diseased—such as in hepatitis or cirrhosis—gamma-glutamyl transferase within liver cells is released into the bloodstream, leading to elevated blood GGT levels. Ursodeoxycholic acid capsules, a commonly used choleretic agent, improve bile composition by reducing cholesterol and bilirubin content in bile, thereby alleviating the burden on the liver and promoting hepatocyte repair and regeneration. This process helps lower GGT levels elevated due to liver disease.
When kidney disease occurs—such as nephritis or nephrotic syndrome—elevated blood GGT levels may result from impaired glomerular filtration or tubular reabsorption dysfunction. However, the primary mechanism of action of ursodeoxycholic acid capsules does not directly target kidney diseases; instead, it mainly improves liver function through its choleretic effect. Therefore, in cases of elevated GGT caused by kidney disease, the enzyme-lowering effect of ursodeoxycholic acid is limited. It may exert some anti-inflammatory effects but cannot directly reduce GGT levels.
Patients should follow their doctor's instructions when taking ursodeoxycholic acid capsules, adhering to the prescribed dosage and schedule, while monitoring both therapeutic effects and potential adverse reactions. During treatment, patients should maintain healthy lifestyle habits, avoid high-fat foods and alcohol consumption, and undergo regular check-ups to monitor changes in liver function parameters.
